Cargando…
Mastocytosis, MCAS, and Related Disorders—Diagnosis, Classification, and Therapy
Autores principales: | Niedoszytko, Marek, Valent, Peter, Nedoszytko, Bogusław |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8125991/ https://www.ncbi.nlm.nih.gov/pubmed/34068468 http://dx.doi.org/10.3390/ijms22095024 |
Ejemplares similares
-
Diagnosis, Classification and Management of Mast Cell Activation Syndromes (MCAS) in the Era of Personalized Medicine
por: Valent, Peter, et al.
Publicado: (2020) -
Mediator-Related Symptoms and Anaphylaxis in Children with Mastocytosis
por: Brockow, Knut, et al.
Publicado: (2021) -
Risk and management of patients with mastocytosis and MCAS in the SARS-CoV-2 (COVID-19) pandemic: Expert opinions
por: Valent, Peter, et al.
Publicado: (2020) -
Association of mastocytosis with interleukin 31 gene polymorphism
por: Nedoszytko, Boguslaw, et al.
Publicado: (2015) -
Epigenetic Changes in Neoplastic Mast Cells and Potential Impact in Mastocytosis
por: Reszka, Edyta, et al.
Publicado: (2021)